Melinta is in Orlando, Florida at the HealthTrust University Conference. Visit with the team at booth 644 starting today. #HTU2024
Melinta Therapeutics’ Post
More Relevant Posts
-
Connect with Parexel at #ACRP2024 in Anaheim, CA on May 3-6. Visit our team at booth #304 and don't miss my colleague Elizabeth Edwards' presentation on Advancing Clinical Trials as a Team! Let me know if you would like to connect with us at the event! For more information on our speakers or to schedule a meeting, follow the link below. #ClinicalResearch #ClinicalTrials #ClinicalOperations #WithHeart
-
Connect with Parexel at #ACRP2024 in Anaheim, CA on May 3-6. Visit our team at booth #304 and don't miss my colleague Elizabeth Edwards' presentation on Advancing Clinical Trials as a Team! Let me know if you would like to connect with us at the event! For more information on our speakers or to schedule a meeting, follow the link below. #ClinicalResearch #ClinicalTrials #ClinicalOperations #WithHeart
ACRP 2024 :: Parexel
share.parexel.social
-
Connect with Parexel at #ACRP2024 in Anaheim, CA on May 3-6. Visit our team at booth #304 and don't miss my colleague Elizabeth Edwards' presentation on Advancing Clinical Trials as a Team! Let me know if you would like to connect with us at the event! For more information on our speakers or to schedule a meeting, follow the link below. #ClinicalResearch #ClinicalTrials #ClinicalOperations #WithHeart
ACRP 2024 :: Parexel
share.parexel.social
-
This past Wednesday, our President and Chief Executive Officer took the stage at HLTH USA to open the #GLP1 Summit and provide his perspective on the landscape of #cardiometabolic disease management. Key takeaways: 1️⃣ Despite spending nearly 2X more on healthcare than peer countries, the health status of Americans is deteriorating. From 2020 to 2050, the percentage of U.S. adults with chronic conditions is projected to increase by 12.4 percentage points. 2️⃣ Between 2020 and 2022, prescription volumes for GLP-1 medications increased 300%, and in 2021, national spending on #semaglutide (the peptide name for drugs like #Ozempic and #Wegovy) totaled $10.7B. 3️⃣ The increase in GLP-1 use does not correlate with clinical indication. Just over half of patients taking GLP-1s have a history of type 2 diabetes or have an associated medical visit with their prescription. Explore more research on GLP-1s and metabolic health: https://lnkd.in/eGKQsQSs #bebold #healthcare #healthinnovation #futureofhealth #HLTH
This has been the BEST and the BOLDEST HLTH yet 💥 #HLTHUSA 2024, that's a wrap! Thank you to our amazing speakers, sponsors, partners, and attendees for making this year one to remember. See you next year back here at the Venetian October 19-22, 2025! 🦄
-
Check out this important panel discussion that features my brilliant sister, Jen Jolley!
I am thrilled that we are able to provide this panel discussion and offer CEUs in February. Grateful to Nicole Gorden, Colleen Heiser, MSEd, Jen Jolley, and Katelynn Wilee for the thought and care they put into helping organize this event.
-
-
#ACRP2024 is right around the corner! Connect with me and the Parexel team in Anaheim, CA on May 3-6. Visit our team at booth #304 and don't miss my colleague Elizabeth Edwards' presentation on Advancing Clinical Trials as a Team. Let me know if I'll see you there! For more information on our speakers or to schedule a meeting, follow the link below! #ClinicalResearch #ClinicalTrials #ClinicalOperations #WithHeart
ACRP 2024 :: Parexel
share.parexel.social
-
Over the past decade, the level and extent of regulatory risks and exposures facing the Customs Broker and Freight Forwarding community has increased significantly. There are many different insurance covers that can safeguard your business – however, we want to focus on the two key covers that are critical for this industry. Our Senior Broker Paul Mikula will be speaking from 11:30am until 11:50am on day 1 of the 2024 #IFCBAA National Conference about all things Professional Indemnity and Cyber Insurance Risks. Understanding, Mitigating and Adapting. You won't want to miss this session!
We are excited to announce that we have finalised the second version of the 2024 National Conference Program. The team have put together a diverse and engaging speaker line up and this conference promises to be bigger and better with senior industry and regulatory bodies presenting over an action packed 3-day event. You won't want to miss this event! Scott Carson Jodie Murray Brad Leonard Praveen Jomy (George) Phil Gray
-
It’s officially conference month! What are you most excited for at the West Coast Symposium?! 🌴 Not registered yet? No worries, there’s still time! Reserve your spot before this Friday, May 3 to lock in Last Chance Rates 💰https://bit.ly/3Upfizp #WestCoastSymposium24 #addictiontreatment #behavioralhealth #continuingeducation #continuingmedicaleducation
-
-
Cultivating a #PatientPartnership mindset by developing relationships with each other. It matters that we take the time to do this. Change happens when we trust enough to utilise individual and collective knowledge and allow innovation to happen. Together we are laying the foundation for better health&social care services in #OurHSE #BetterTogether #WeAreAllPatients #HSEPatientConf2024 Colm Henry Joe R. Iolo Eilian Bernard Gloster
Have you met our speakers yet for our 2nd National Patient and Public Partnership Conference on the 24th September 2024 https://lnkd.in/eHFW7ezR
-
Headed to the NAACOS Spring Conference? Let’s chat about your ACO’s PY2025 goals, and how CareJourney’s insights can help you build an actionable, data-driven strategy for success! Grab some time at the link below ⬇️
Our team is excited to join industry-leading value-based care organizations this week at National Association of ACOs Spring Conference! Will you be there? Let's connect ➡ https://lnkd.in/euJ2Kauk #NAACOs #VBC #valuebasedcare #mssp #acoreach #carejourney
Heading to NAACOS Spring 2024 Conference? Let's Meet!
calendly.com
